Our research
We are translating cancer research developed by leading academics and clinicians into better lives for patients.
With strong partnerships across the cancer research community in Wales we are ideally placed to develop the next generation of cancer treatments.
Case study: ATTEST
A Phase 1 first-in-human clinical trial pioneering the use of genetically modified viruses to exclusively target cancer cells.
Case study: MORab-202
An Early Phase study looking at an antibody to a folate receptor that is expressed in a number of different cancers, linked to a drug that can kill cancer cells.
Case study: MonumenTAL-6
A study comparing the effectiveness of the drugs Tal-pomalidomide (Tal-P) or Tal-Tec when taken in combination with others to treat blood cancer.
